[HTML][HTML] Autophagy, an accomplice or antagonist of drug resistance in HCC?

Y Wu, J Zhang, Q Li - Cell Death & Disease, 2021 - nature.com
Hepatocellular carcinoma (HCC) is a highly lethal malignancy characterized by poor
prognosis and a low 5-year survival rate. Drug treatment is proving to be effective in anti …

Autophagy, an accomplice or antagonist of drug resistance in HCC?

Y Wu, J Zhang, Q Li - Cell Death & Disease, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Hepatocellular carcinoma (HCC) is a highly
lethal malignancy characterized by poor prognosis and a low 5-year survival rate. Drug …

Autophagy, an accomplice or antagonist of drug resistance in HCC?

Y Wu, J Zhang, Q Li - Cell death & disease, 2021 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is a highly lethal malignancy characterized by poor
prognosis and a low 5-year survival rate. Drug treatment is proving to be effective in anti …

[HTML][HTML] Autophagy, an accomplice or antagonist of drug resistance in HCC?

Y Wu, J Zhang, Q Li - Cell Death & Disease, 2021 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is a highly lethal malignancy characterized by poor
prognosis and a low 5-year survival rate. Drug treatment is proving to be effective in anti …

Autophagy, an accomplice or antagonist of drug resistance in HCC?

Y Wu, J Zhang, Q Li - Cell Death and Disease, 2021 - search.proquest.com
Hepatocellular carcinoma (HCC) is a highly lethal malignancy characterized by poor
prognosis and a low 5-year survival rate. Drug treatment is proving to be effective in anti …

Autophagy, an accomplice or antagonist of drug resistance in HCC?

Y Wu, J Zhang, Q Li - Cell Death & Disease, 2021 - europepmc.org
Hepatocellular carcinoma (HCC) is a highly lethal malignancy characterized by poor
prognosis and a low 5-year survival rate. Drug treatment is proving to be effective in anti …

Autophagy, an accomplice or antagonist of drug resistance in HCC?

Y Wu, J Zhang, Q Li - Cell Death & Disease, 2021 - search.ebscohost.com
Hepatocellular carcinoma (HCC) is a highly lethal malignancy characterized by poor
prognosis and a low 5-year survival rate. Drug treatment is proving to be effective in anti …